EMEA (Europe, Middle East and Africa) Rotavirus Vaccine Market Report 2017

December 2017 | 104 pages | ID: EF6009FB507EN
QYResearch

Abstracts

In this report, the EMEA Rotavirus Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Rotavirus Vaccine for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Rotavirus Vaccine market competition by top manufacturers/players, with Rotavirus Vaccine sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• GSK
• Sanofi

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• By Type
• Oral
• Others
• By Type 2
• Live Attenuated Vaccine
• Inactivated Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinics
• Public Services
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Rotavirus Vaccine Market Report 2017

1 ROTAVIRUS VACCINE OVERVIEW

1.1 Product Overview and Scope of Rotavirus Vaccine
1.2 Classification of Rotavirus Vaccine
  1.2.1 EMEA Rotavirus Vaccine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Rotavirus Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Oral
  1.2.4 Others
1.3 EMEA Rotavirus Vaccine Market by Application/End Users
  1.3.1 EMEA Rotavirus Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Clinics
  1.3.4 Public Services
  1.3.5 Others
1.4 EMEA Rotavirus Vaccine Market by Region
  1.4.1 EMEA Rotavirus Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Rotavirus Vaccine (2012-2022)
  1.5.1 EMEA Rotavirus Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Rotavirus Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA ROTAVIRUS VACCINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Rotavirus Vaccine Market Competition by Players/Manufacturers
  2.1.1 EMEA Rotavirus Vaccine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Rotavirus Vaccine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Rotavirus Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Rotavirus Vaccine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Rotavirus Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Rotavirus Vaccine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Rotavirus Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Rotavirus Vaccine (Volume) by Application
2.4 EMEA Rotavirus Vaccine (Volume and Value) by Region
  2.4.1 EMEA Rotavirus Vaccine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Rotavirus Vaccine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Rotavirus Vaccine Sales Price by Region (2012-2017)

3 EUROPE ROTAVIRUS VACCINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Rotavirus Vaccine Sales and Value (2012-2017)
  3.1.1 Europe Rotavirus Vaccine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Rotavirus Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Rotavirus Vaccine Sales and Market Share by Type
3.3 Europe Rotavirus Vaccine Sales and Market Share by Application
3.4 Europe Rotavirus Vaccine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Rotavirus Vaccine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Rotavirus Vaccine Revenue by Countries (2012-2017)
  3.4.3 Germany Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  3.4.4 France Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  3.4.5 UK Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Rotavirus Vaccine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ROTAVIRUS VACCINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Rotavirus Vaccine Sales and Value (2012-2017)
  4.1.1 Middle East Rotavirus Vaccine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Rotavirus Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Rotavirus Vaccine Sales and Market Share by Type
4.3 Middle East Rotavirus Vaccine Sales and Market Share by Application
4.4 Middle East Rotavirus Vaccine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Rotavirus Vaccine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Rotavirus Vaccine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Rotavirus Vaccine Sales and Growth Rate (2012-2017)

5 AFRICA ROTAVIRUS VACCINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Rotavirus Vaccine Sales and Value (2012-2017)
  5.1.1 Africa Rotavirus Vaccine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Rotavirus Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Rotavirus Vaccine Sales and Market Share by Type
5.3 Africa Rotavirus Vaccine Sales and Market Share by Application
5.4 Africa Rotavirus Vaccine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Rotavirus Vaccine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Rotavirus Vaccine Revenue by Countries (2012-2017)
  5.4.3 South Africa Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Rotavirus Vaccine Sales and Growth Rate (2012-2017)

6 EMEA ROTAVIRUS VACCINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Rotavirus Vaccine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Rotavirus Vaccine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Rotavirus Vaccine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview

7 ROTAVIRUS VACCINE MANUFACTURING COST ANALYSIS

7.1 Rotavirus Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rotavirus Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Rotavirus Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rotavirus Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ROTAVIRUS VACCINE MARKET FORECAST (2017-2022)

11.1 EMEA Rotavirus Vaccine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Rotavirus Vaccine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Rotavirus Vaccine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Rotavirus Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Rotavirus Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Rotavirus Vaccine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Rotavirus Vaccine
Figure EMEA Rotavirus Vaccine Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Rotavirus Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Others Product Picture
Figure EMEA Rotavirus Vaccine Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Rotavirus Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Public Services Examples
Table Key Downstream Customer in Public Services
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Rotavirus Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Rotavirus Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Rotavirus Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Rotavirus Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Rotavirus Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Rotavirus Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Rotavirus Vaccine Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Rotavirus Vaccine Sales Share by Players (2012-2017)
Figure 2016 Rotavirus Vaccine Sales Share by Players
Figure 2017 Rotavirus Vaccine Sales Share by Players
Figure EMEA Rotavirus Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Rotavirus Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Rotavirus Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Rotavirus Vaccine Revenue Share by Players
Table 2017 EMEA Rotavirus Vaccine Revenue Share by Players
Table EMEA Rotavirus Vaccine Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Rotavirus Vaccine Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Rotavirus Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Rotavirus Vaccine by Type (2012-2017)
Figure EMEA Rotavirus Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Rotavirus Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Rotavirus Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Rotavirus Vaccine by Type in 2016
Table EMEA Rotavirus Vaccine Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Rotavirus Vaccine Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Rotavirus Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Rotavirus Vaccine by Application (2012-2017)
Figure EMEA Rotavirus Vaccine Sales Market Share by Application in 2016
Table EMEA Rotavirus Vaccine Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Rotavirus Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Rotavirus Vaccine by Region (2012-2017)
Figure EMEA Rotavirus Vaccine Sales Market Share in 2016
Table EMEA Rotavirus Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Rotavirus Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Rotavirus Vaccine by Region (2012-2017)
Figure EMEA Rotavirus Vaccine Revenue Market Share Regions in 2016
Table EMEA Rotavirus Vaccine Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Rotavirus Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Rotavirus Vaccine Sales (K Pcs) by Type (2012-2017)
Table Europe Rotavirus Vaccine Market Share by Type (2012-2017)
Figure Europe Rotavirus Vaccine Market Share by Type in 2016
Table Europe Rotavirus Vaccine Sales (K Pcs) by Application (2012-2017)
Table Europe Rotavirus Vaccine Market Share by Application (2012-2017)
Figure Europe Rotavirus Vaccine Market Share by Application in 2016
Table Europe Rotavirus Vaccine Sales (K Pcs) by Countries (2012-2017)
Table Europe Rotavirus Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Rotavirus Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Rotavirus Vaccine Sales Market Share by Countries in 2016
Table Europe Rotavirus Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Rotavirus Vaccine Revenue Market Share by Countries in 2016
Figure Germany Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Rotavirus Vaccine Sales (K Pcs) by Type (2012-2017)
Table Middle East Rotavirus Vaccine Market Share by Type (2012-2017)
Figure Middle East Rotavirus Vaccine Market Share by Type (2012-2017)
Table Middle East Rotavirus Vaccine Sales (K Pcs) by Applications (2012-2017)
Table Middle East Rotavirus Vaccine Market Share by Applications (2012-2017)
Figure Middle East Rotavirus Vaccine Sales Market Share by Application in 2016
Table Middle East Rotavirus Vaccine Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Rotavirus Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Rotavirus Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Rotavirus Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Rotavirus Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Rotavirus Vaccine Sales (K Pcs) by Type (2012-2017)
Table Africa Rotavirus Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Rotavirus Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Rotavirus Vaccine Sales Market Share by Type in 2016
Table Africa Rotavirus Vaccine Sales (K Pcs) by Application (2012-2017)
Table Africa Rotavirus Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Rotavirus Vaccine Sales Market Share by Application (2012-2017)
Table Africa Rotavirus Vaccine Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Rotavirus Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Rotavirus Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Rotavirus Vaccine Sales Market Share by Countries in 2016
Table Africa Rotavirus Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Rotavirus Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Merck Rotavirus Vaccine Basic Information List
Table Merck Rotavirus Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck Rotavirus Vaccine Sales Market Share in EMEA (2012-2017)
Figure Merck Rotavirus Vaccine Revenue Market Share in EMEA (2012-2017)
Table GSK Rotavirus Vaccine Basic Information List
Table GSK Rotavirus Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure GSK Rotavirus Vaccine Sales Market Share in EMEA (2012-2017)
Figure GSK Rotavirus Vaccine Revenue Market Share in EMEA (2012-2017)
Table Sanofi Rotavirus Vaccine Basic Information List
Table Sanofi Rotavirus Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Rotavirus Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi Rotavirus Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sanofi Rotavirus Vaccine Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rotavirus Vaccine
Figure Manufacturing Process Analysis of Rotavirus Vaccine
Figure Rotavirus Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Rotavirus Vaccine Major Manufacturers in 2016
Table Major Buyers of Rotavirus Vaccine
Table Distributors/Traders List
Figure EMEA Rotavirus Vaccine Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Rotavirus Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Rotavirus Vaccine Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Rotavirus Vaccine Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Rotavirus Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Rotavirus Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Rotavirus Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Rotavirus Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Rotavirus Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Rotavirus Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Rotavirus Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Rotavirus Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Rotavirus Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Rotavirus Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Rotavirus Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Rotavirus Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Rotavirus Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Rotavirus Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Rotavirus Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Rotavirus Vaccine Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Rotavirus Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Rotavirus Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Rotavirus Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources